Clinical trial
ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells
NCT00400556 · Peter MacCallum Cancer Centre, Australia, Other · Completed
Key facts
| NCT number | NCT00400556 |
|---|---|
| Title | ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells |
| Official title | A Phase I Study of Haematopoietic Stem Cell Mobilization Using G-CSF With ATRA in Patients With Cutaneous Lymphoma and Multiple Myeloma |
| Lead sponsor | Peter MacCallum Cancer Centre, Australia, Other |
| Collaborators | The Leukemia and Lymphoma Society |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Cutaneous Lymphoma |
| Intervention type | Drug |
| Interventions | ATRA plus G-CSF (filgrastim, NEUPOGEN (R)) combination |
| Enrollment | 6 |
| Start date | Mar 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Nov 17, 2006 |
| Last update posted | Nov 17, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: